Adição na publicação
#15.35
10/05/2021
RPI 2648
Application data
Number
112019009903Type
Filing
Publication
PCT
EP2017079549 The application was abandoned: examination was not requested within the 36 months following the 11/17/2017 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/05/2021. We update with every new RPI gazette, published weekly.
Applicants
NEUROVIVE PHARMACEUTICAL AB
SE
Inventors
A. G. (pessoa física)
SE
M. H. (pessoa física)
SE
M. G. (pessoa física)
GB
S. M. (pessoa física)
GB
IPC Classification
Priority claims
DK
PA 2016 70920 · 11/18/2016
DK
PA 2017 70054 · 01/30/2017
Abstract
A presente invenção refere-se aos usos de análogos macrocíclicos de sangliferina no tratamento de câncer, especialmente de câncer de fígado.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/05/2021
RPI 2648
#11.1.1
05/11/2021
RPI 2627
#11.1
02/23/2021
RPI 2616
#1.3
08/13/2019
RPI 2536
#1.1
05/28/2019
RPI 2525
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.